CAMBRIDGE, Mass.--Chris Sander, a researcher with the European Molecular Biology Laboratory (EMBL) who is internationally recognized as a pioneer in the field of bioinformatics, has agreed to serve as chief information officer of Millennium Information, a new spinoff from Millennium Pharmaceuticals here. In the new position Sander will lead the company "in conceptualizing and prototyping information products and services."
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.